Calidi Biotherapeutics, Inc. (CLDI) vs Clearmind Medicine Inc. (CMND)

Calidi Biotherapeutics, Inc. and Clearmind Medicine Inc. are both Biotechnology companies. Calidi Biotherapeutics, Inc. and Clearmind Medicine Inc. are of similar size ($3.0M and $2.8M). Across the 10 metrics below, Clearmind Medicine Inc. leads on 6 and Calidi Biotherapeutics, Inc. on 4.

Valuation

Metric CLDI CMND Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.51 0.10 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.04 1.46 0.74
EV/Sales n/m n/m 10.73
Earnings yield (4,805.31%) (11,553.20%) (28.84%)
Free cash flow yield (1,115.26%) (558.57%) (23.03%)

Profitability

Metric CLDI CMND Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (900.56%) (106.98%) (57.72%)
Return on assets (283.36%) (71.81%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLDI CMND Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 83.31% 55.10% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CLDI CMND Biotechnology median
Debt to equity 0.24 0.13 0.00
Current ratio 1.68 4.31 4.73
Net debt to EBITDA 0.26 0.68 0.96

Dividend

Metric CLDI CMND Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric CLDI CMND Biotechnology median
Market cap 2.97m 2.83m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack